• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻断盐皮质激素受体可逆转肥胖小鼠的脂肪细胞功能障碍和胰岛素抵抗。

Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.

作者信息

Hirata Ayumu, Maeda Norikazu, Hiuge Aki, Hibuse Toshiyuki, Fujita Koichi, Okada Takuya, Kihara Shinji, Funahashi Tohru, Shimomura Iichiro

机构信息

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2-B5 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Cardiovasc Res. 2009 Oct 1;84(1):164-72. doi: 10.1093/cvr/cvp191. Epub 2009 Jun 8.

DOI:10.1093/cvr/cvp191
PMID:19505930
Abstract

AIMS

In obesity, chronic low-grade inflammation and overproduction of reactive oxygen species (ROS) in fat contribute to the development of metabolic syndrome. Suppression of inflammation and ROS production in fat may attenuate the metabolic syndrome. Activation of mineralocorticoid receptor (MR) promotes inflammation in heart, kidney, and vasculature via ROS generation. However, the significance of MR in fat remains elusive. Here we investigated whether MR blockade attenuates obesity-related insulin resistance and improves adipocyte dysfunction.

METHODS AND RESULTS

Obese ob/ob and db/db mice were treated with eplerenone, a MR antagonist, for 3 weeks. 3T3-L1 adipocytes were treated with aldosterone or H2O2, with and without eplerenone or MR-siRNA. High levels of MR mRNA were detected in adipose tissue of obese ob/ob and db/db mice. Eplerenone treatment significantly reduced insulin resistance, suppressed macrophage infiltration and ROS production in adipose tissues, and corrected the mRNA levels of obesity-related genes in obese mice. In 3T3-L1 adipocytes, aldosterone and H2O2 increased intracellular ROS levels and MR blockade inhibited such increases. H2O2 and aldosterone resulted in dysregulation of mRNAs of various genes related to ROS and cytokines, whereas MR blockade corrected such changes.

CONCLUSION

MR blockade attenuates obesity-related insulin resistance partly through reduction of fat ROS production, inflammatory process, and induction of cytokines.

摘要

目的

在肥胖症中,脂肪组织中的慢性低度炎症和活性氧(ROS)的过度产生会导致代谢综合征的发展。抑制脂肪组织中的炎症和ROS产生可能会减轻代谢综合征。盐皮质激素受体(MR)的激活通过ROS的产生促进心脏、肾脏和血管的炎症。然而,MR在脂肪组织中的作用仍不清楚。在此,我们研究了MR阻断是否能减轻肥胖相关的胰岛素抵抗并改善脂肪细胞功能障碍。

方法和结果

肥胖的ob/ob和db/db小鼠用MR拮抗剂依普利酮治疗3周。3T3-L1脂肪细胞用醛固酮或H2O2处理,同时或不同时使用依普利酮或MR-siRNA。在肥胖的ob/ob和db/db小鼠的脂肪组织中检测到高水平的MR mRNA。依普利酮治疗显著降低了胰岛素抵抗,抑制了脂肪组织中的巨噬细胞浸润和ROS产生,并纠正了肥胖小鼠中肥胖相关基因的mRNA水平。在3T3-L1脂肪细胞中,醛固酮和H2O2增加了细胞内ROS水平,而MR阻断抑制了这种增加。H2O2和醛固酮导致与ROS和细胞因子相关的各种基因的mRNA失调,而MR阻断纠正了这种变化。

结论

MR阻断部分通过减少脂肪ROS产生、炎症过程和细胞因子的诱导来减轻肥胖相关的胰岛素抵抗。

相似文献

1
Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.阻断盐皮质激素受体可逆转肥胖小鼠的脂肪细胞功能障碍和胰岛素抵抗。
Cardiovasc Res. 2009 Oct 1;84(1):164-72. doi: 10.1093/cvr/cvp191. Epub 2009 Jun 8.
2
Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.糖皮质激素-盐皮质激素受体通路在肥胖相关脂肪细胞功能障碍中的作用。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):182-7. doi: 10.1016/j.bbrc.2012.01.139. Epub 2012 Feb 3.
3
Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.依普利酮可预防肥胖诱导的炎性小体激活和葡萄糖不耐受。
J Endocrinol. 2017 Dec;235(3):179-191. doi: 10.1530/JOE-17-0351. Epub 2017 Aug 30.
4
Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.盐皮质激素受体阻断改善大鼠心脏胰岛素敏感性及一种可能的分子机制
Cell Physiol Biochem. 2016;39(3):860-70. doi: 10.1159/000447796. Epub 2016 Aug 9.
5
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.脂肪细胞盐皮质激素受体激活导致代谢综合征并诱导前列腺素D2合酶。
Hypertension. 2015 Jul;66(1):149-57. doi: 10.1161/HYPERTENSIONAHA.114.04981. Epub 2015 May 11.
6
Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.盐皮质激素受体在皮质类固醇诱导的脂肪生成中的关键作用。
FASEB J. 2007 Jul;21(9):2185-94. doi: 10.1096/fj.06-7970com. Epub 2007 Mar 23.
7
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.盐皮质激素受体阻断可逆转肥胖相关的脂联素、过氧化物酶体增殖物激活受体γ和促炎脂肪因子表达的变化。
Circulation. 2008 Apr 29;117(17):2253-61. doi: 10.1161/CIRCULATIONAHA.107.748640. Epub 2008 Apr 21.
8
Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat.肥胖中的脂肪低温及其与周期同源物1、胰岛素敏感性和脂肪炎症的关联。
PLoS One. 2014 Nov 14;9(11):e112813. doi: 10.1371/journal.pone.0112813. eCollection 2014.
9
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.内皮矿物ocorticoid 受体激活介导饮食诱导肥胖中的内皮功能障碍。
Eur Heart J. 2013 Dec;34(45):3515-24. doi: 10.1093/eurheartj/eht095. Epub 2013 Apr 17.
10
Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.罗格列酮对脂联素和 S100A8 水平的动态影响。
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):792-9. doi: 10.1161/ATVBAHA.110.221747. Epub 2011 Jan 13.

引用本文的文献

1
Effect of inulin from dahlia tubers () extract on insulitis severity and insulin expression in diabetic rats.大丽花块茎中菊粉提取物对糖尿病大鼠胰岛炎严重程度及胰岛素表达的影响。
Biomedicine (Taipei). 2024 Sep 1;14(3):31-39. doi: 10.37796/2211-8039.1460. eCollection 2024.
2
Dysregulation of HO-1-SIRT1 Axis is Associated with AngII-Induced Adipocyte Dysfunction.HO-1-SIRT1轴的失调与血管紧张素II诱导的脂肪细胞功能障碍有关。
J Clin Med Sci. 2024;8(2). Epub 2024 May 20.
3
The molecular mechanism of macrophage-adipocyte crosstalk in maintaining energy homeostasis.
巨噬细胞-脂肪细胞串扰在维持能量平衡中的分子机制。
Front Immunol. 2024 Apr 8;15:1378202. doi: 10.3389/fimmu.2024.1378202. eCollection 2024.
4
Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism.通过原发性醛固酮增多症患者中盐皮质激素受体拮抗剂的降压作用预测内源性盐皮质激素受体活性。
Hypertens Res. 2024 Jun;47(6):1707-1718. doi: 10.1038/s41440-024-01651-5. Epub 2024 Mar 28.
5
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review.原发性醛固酮增多症相关心血管并发症研究的最新进展:简要综述
Hypertens Res. 2024 May;47(5):1103-1119. doi: 10.1038/s41440-023-01538-x. Epub 2024 Jan 16.
6
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.醛固酮受体过度激活:用非甾体类醛固酮受体拮抗剂靶向全身影响。
Diabetologia. 2024 Feb;67(2):246-262. doi: 10.1007/s00125-023-06031-1. Epub 2023 Dec 21.
7
Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction.醛固酮受体拮抗剂可预防 2 型家族性部分脂肪营养不良棕色脂肪细胞功能障碍。
Cells. 2023 Nov 7;12(22):2586. doi: 10.3390/cells12222586.
8
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances.新型盐皮质激素受体拮抗剂非奈利酮在慢性肾脏病中的作用:作用机制与临床进展
Clin Exp Nephrol. 2024 Feb;28(2):125-135. doi: 10.1007/s10157-023-02413-2. Epub 2023 Oct 17.
9
Neutral Effect of Skeletal Muscle Mineralocorticoid Receptor on Glucose Metabolism in Mice.骨骼肌盐皮质激素受体对小鼠糖代谢无影响。
Int J Mol Sci. 2023 Apr 18;24(8):7412. doi: 10.3390/ijms24087412.
10
Effects of very low-calorie ketogenic diet on hypothalamic-pituitary-adrenal axis and renin-angiotensin-aldosterone system.极低卡路里生酮饮食对下丘脑-垂体-肾上腺轴和肾素-血管紧张素-醛固酮系统的影响。
J Endocrinol Invest. 2023 Aug;46(8):1509-1520. doi: 10.1007/s40618-023-02068-6. Epub 2023 Apr 5.